MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4

Amplification of the MYCN oncogene, a member of the MYC family of transcriptional regulators, is one of the most powerful prognostic markers identified for poor outcome in neuroblastoma, the most common extracranial solid cancer in childhood. While MYCN has been established as a key driver of malign...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncotarget
Huvudupphovsmän: Xue, Chengyuan, Yu, Denise M.T., Gherardi, Samuele, Koach, Jessica, Milazzo, Giorgio, Gamble, Laura, Liu, Bing, Valli, Emanuele, Russell, Amanda J., London, Wendy B., Liu, Tao, Cheung, Belamy B., Marshall, Glenn M., Perini, Giovanni, Haber, Michelle, Norris, Murray D.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Impact Journals LLC 2016
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342392/
https://ncbi.nlm.nih.gov/pubmed/27448979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10709
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk